financetom
Business
financetom
/
Business
/
Bancorp Insider Sold Shares Worth $751,557, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bancorp Insider Sold Shares Worth $751,557, According to a Recent SEC Filing
Sep 11, 2025 1:55 PM

04:36 PM EDT, 09/11/2025 (MT Newswires) -- Ryan Harris, Executive Vice President, Head of Fintech Solutions, on September 10, 2025, sold 9,841 shares in Bancorp (TBBK) for $751,557. Following the Form 4 filing with the SEC, Harris has control over a total of 132,081 common shares of the company, with 129,598 shares held directly and 2,483 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1295401/000203985225000168/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
CG Oncology Reports Durable Responses for Cretostimogene in Bladder Cancer Treatment; Shares Rise
CG Oncology Reports Durable Responses for Cretostimogene in Bladder Cancer Treatment; Shares Rise
May 25, 2025
11:05 AM EDT, 04/28/2025 (MT Newswires) -- CG Oncology ( CGON ) on Monday reported durable long-term outcomes from its phase 3 Bond-003 trial evaluating cretostimogene grenadenorepvec in patients with high-risk non-muscle invasive bladder cancer, or NMIBC, unresponsive to Bacillus Calmette Guerin. In Cohort C, 75.5% of patients achieved a complete response at any point during the study. At 24...
Delcath Systems Gets FDA Clearance to Start Phase 2 Trial of Hepzato for Metastatic Breast Cancer
Delcath Systems Gets FDA Clearance to Start Phase 2 Trial of Hepzato for Metastatic Breast Cancer
May 25, 2025
11:04 AM EDT, 04/28/2025 (MT Newswires) -- Delcath Systems ( DCTH ) said Monday it has received US Food and Drug Administration clearance to begin patient enrollment for a phase 2 clinical trial evaluating Hepzato in combination with standard of care for liver-dominant metastatic breast cancer. The trial will assess the safety and efficacy of this combination therapy, aiming to...
Commvault Expands Partnership With CrowdStrike to Provide Cyber Recovery, Incident Response Services
Commvault Expands Partnership With CrowdStrike to Provide Cyber Recovery, Incident Response Services
May 25, 2025
11:04 AM EDT, 04/28/2025 (MT Newswires) -- Commvault Systems ( CVLT ) said Monday it has expanded its collaboration with CrowdStrike ( CRWD ) to provide cyber recovery and incident response services to clients. Financial terms were not disclosed. Commvault ( CVLT ) said it will offer its Guardian retainer-based services offering, while CrowdStrike ( CRWD ) will provide its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved